A reference desk, not a vendor

What this desk is

Peptide Peptalk is an independent editorial digest covering nootropic and neuroactive research peptides studied for focus, clarity, and cognitive performance. Its scope is currently: Semax and Selank — two synthetic heptapeptides with a substantial Russian research history, active nootropic community interest, and a genuine mechanistic story that deserves careful reading rather than either hype or dismissal.

The site has no products to sell, no vendor relationships, no referral arrangements, and no commercial interest in any compound it covers. It does not have a clinic, a telehealth arm, a compounding pharmacy relationship, or an affiliate program. Its only interest is in accurately summarizing the peer-reviewed literature and the community-reported experience that surrounds these compounds — keeping the two layers rigorously distinct at all times.

The audience is people who are curious about what the research on these peptides actually says: researchers, students, clinicians, and informed lay readers who want accurate, well-cited information rather than promotional copy.

Editorial method

Every claim on this site either cites a specific peer-reviewed source or is explicitly labeled as anecdotal community report. Sources are drawn from PubMed-indexed journals, Doklady Biological Sciences, Frontiers in Pharmacology, and other indexed venues; Russian-language publications are included and noted as such, with English abstracts available via PubMed in most cases. Source selection prioritizes primary research over review articles where both are available, and the species and experimental context of every cited finding are stated explicitly — we do not upgrade a rodent result to a human finding.

Where evidence is preclinical only, single-lab only, or originates from a single country's research tradition without independent replication, we say so. Where community-reported effects are included, they are clearly labeled "anecdotal, not clinical evidence" and separated from the literature-derived content. The site does not give medical advice, does not recommend doses, and does not direct users to suppliers. Any claim on this site that involves a specific number (dose, concentration, receptor affinity) is drawn verbatim from the cited study and attributed to the species and conditions of that study.

Independence and disclaimer

Peptide Peptalk is not affiliated with any pharmaceutical company, research institution, or government agency. It is not a clinical service, a treatment provider, or a supplement brand. The compounds covered on this site — Semax and Selank — are not FDA-approved for any human indication and are handled as research chemicals outside Russia and Ukraine. Nothing on this site constitutes medical advice, a treatment recommendation, or a solicitation to purchase any compound.

Peptide Peptalk covers these topics because they are genuinely interesting and because accurate, well-cited information about them is difficult to find outside primary literature. The site exists to lower the friction of reading that literature carefully.